Amphion Innovations plc
Issue of Equity

London and New York, 9 September 2011 – Amphion Innovations plc (LSE: AMP) (“Amphion” or the “Company”), the developer of medical and technology businesses today announces that, at a Board meeting held today, the Company has issued 463,474 ordinary shares, representing 0.34% of the enlarged issued share capital, to a former non-executive director, in lieu of fees, priced at 2.625 pence, being the average of the closing mid-market price for the five days leading up to the market close on 31 May 201, the date that payment was due.

Admission of the 463,474 new ordinary shares, ranking pari passu with the existing ordinary shares, is expected on 16 September 2011. Following this allotment the total issued share capital of the Company will increase to 134,689,324 ordinary shares with each share holding one voting right.


For further information please contact

Amphion Innovations plc
Charlie Morgan
+1 (212) 210 6224

Cardew Group
Tim Robertson
+44 20 7930 0777

Seymour Pierce (Nominated Adviser)
Freddy Crossley
+44 7107 8347


About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 10 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.

On the web: